Literature DB >> 1691788

Role of hydrogen bonding in ligand interaction with the N-methyl-D-aspartate receptor ion channel.

P D Leeson1, R W Carling, K James, J D Smith, K W Moore, E H Wong, R Baker.   

Abstract

Displacement of [3H]MK-801 (dizocilpine, 1) binding to rat brain membranes has been used to evaluate the affinities of novel dibenzocycloalkenimines related to 1 for the ion channel binding site (also known as the phencyclidine or PCP receptor) on the N-methyl-D-aspartate (NMDA) subtype of excitory amino acid receptor. In common with many other agents having actions in the central nervous system, these compounds contain a hydrophobic aromatic moiety and a basic nitrogen atom. The conformational rigidity of these ligands provides a unique opportunity to evaluate the importance of specific geometrical properties that influence active-site recognition, in particular the role of the nitrogen atom in hydrogen-bonding interactions. The relative affinities (IC50s) of hydrocarbon-substituted analogues of 1 and ring homologated cyclooctenimines illustrate the importance of size-limited hydrophobic binding of both aryl rings and of the quaternary C-5 methyl group. Analysis of the binding of a series of the 10 available structurally rigid dibenzoazabicyclo[x.y.z]alkanes, by using molecular modeling techniques, uncovered a highly significant correlation between affinity and a proposed ligand-active site hydrogen bonding vector (r = 0.950, p less than 0.001). These results are used to generate a pharmacophore of the MK-801 recognition site/PCP receptor, which accounts for the binding of all of the known ligands.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691788     DOI: 10.1021/jm00167a005

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Interaction of the NMDA receptor noncompetitive antagonist MK-801 with model and native membranes.

Authors:  J Moring; L A Niego; L M Ganley; M W Trumbore; L G Herbette
Journal:  Biophys J       Date:  1994-12       Impact factor: 4.033

2.  Lurasidone inhibits NMDA receptor antagonist-induced functional abnormality of thalamocortical glutamatergic transmission via 5-HT7 receptor blockade.

Authors:  Motohiro Okada; Kouji Fukuyama; Yuto Ueda
Journal:  Br J Pharmacol       Date:  2019-09-15       Impact factor: 8.739

3.  Molecular design of the N-methyl-D-aspartate receptor binding site for phencyclidine and dizolcipine.

Authors:  A V Ferrer-Montiel; W Sun; M Montal
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

4.  Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc<sup/>.

Authors:  Motohiro Okada; Kouji Fukuyama; Yasuhiro Kawano; Takashi Shiroyama; Yuto Ueda
Journal:  Pharmacol Res Perspect       Date:  2019-01-07

5.  Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor.

Authors:  Kouji Fukuyama; Ryo Kato; Masahiko Murata; Takashi Shiroyama; Motohiro Okada
Journal:  Biomolecules       Date:  2019-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.